Significant Ownership of Column Group IV GP, LP

Signature - Title
/s/ James Evangelista - James Evangelista, Attorney-in-Fact
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Column Group IV GP, LP.

Notify me when Column Group IV GP, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Column Group IV GP, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SRZN Eikon Therapeutics, Inc. Common Stock, $0.0001 par value per share 12% $131,204,153 6,353,712 Tim Kutzkey 06 Feb 2026

Schedules 13D/G Reported by Column Group IV GP, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.